What was APDN's most recent financial performance?

APDN reported a recent EPS of -34.0, falling short of the estimated -22.5. Revenue estimates have also been missed in previous quarters, illustrating ongoing fiscal challenges.

What is the current trading volume for APDN?

As of the pre-market session, APDN's trading volume stands at 2,648,596, significantly above its average of 469,222, indicating heightened investor interest.

How does Meyka AI rate APDN?

Meyka AI assigns APDN a score of 66 out of 100, with a 'B' grade and a hold recommendation, based on sector analysis, financial growth, and key performance metrics.

What are the technical indicators for APDN?

APDN's RSI is 48.31, suggesting neutrality, while the MFI of 90.58 signals an overbought condition. The ADX is 83.91, indicating a strong trend in place.

What is the projected stock price for APDN according to Meyka AI?

Meyka AI forecasts a quarterly stock price of $4.43, representing a potential downside of 21% from its current pre-market price of $5.62. Forecasts are model-based projections and not guarantees.

US Stocks

APDN Pre-Market (23 Dec 2025): Anticipating Earnings Impact

ByHuzaifa Zahoor December 23, 2025December 23, 2025

Applied DNA Sciences, Inc. (NASDAQ: APDN) is drawing attention in pre-market trading with a remarkable 31% price rise, positioning itself for exciting developments ahead of its earnings announcement on December 25, 2025.